Email ID : 
Password : 
Forgot Your Password ? 

Only Report Titles
Titles & Keywords
NOTE: Site best viewed with Internet Explorer
  BIOCHIPS
A Global Strategic Business Report

This report analyzes the worldwide markets for Biochips in Millions of US$. The specific product segments analyzed are DNA Chips, Protein Chips, and Lab Chips. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 89 companies including many key and niche players worldwide such as Affymetrix, Applied Biosystems Group, Biomerieux, Bio-Rad Laboratories, Inc., Caliper Technologies Corp., Cepheid Inc., GE Healthcare Ltd., Takara Bio, Inc., and Zyomyx. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

CODE:    MCP-1026  PAGES:    335
PRICE:    $3950  DATE:       October 2008
COMPANIES:  89  MARKET DATA TABLES:   43
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

 TABLE OF CONTENTS  
  BIOCHIPS (Complete Report) Pages : 335   | $3950
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS4$100
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
A. DNA Chips.....I-3
B. Protein Chips.....I-3
  
   C. Lab Chips.....I-4  
II. EXECUTIVE SUMMARY86$2250
  1. Industry Overview .....II-17 $500  
   Promising Biochips Promote Biological Research.....II-1
Market Scenario across Products and Regions.....II-1
1$100
   DNA Chips Lead the Application Front.....II-2
Probable Industry Directions.....II-2
1$100
   Biochip Technology Boosts Personalised Medicine .....II-3
Biochip Technology Spreads beyond Pharma Industry.....II-3
1$100
   Protein Chips to Shape the Future.....II-4
Proteomics “ Chip” into Biochip Technology.....II-4
Towards Increasing Minaturization.....II-4
1$100
   European Advancements Set Diagnostic Procedures.....II-5
Competitive Scenario .....II-5
Major Participants.....II-5
1$100
   Roche and Affymetrix Taste Success in the Diagnostics Market.....II-6
Growing Partnerships between Pharma and Biotech Companies.....II-6
1$100
   Tech Giants Join the Biochip Fray.....II-7
1$100
  2. Product Overview .....II-88 $600  
   Biochips – Complex Blend of Biochemistry and Electronics .....II-8
Historical Perspective.....II-8
2$200
   Lab-on-a-chip: An Enabled Technology.....II-10
Utility .....II-10
Evolution and Segmentation.....II-10
Differing Perspectives.....II-10
1$100
   Classification of Biochips.....II-111$100
   Manufacturing Systems Used in Biochip Manufacture.....II-12
Working of a Biochip.....II-12
1$100
   A Functional Model.....II-13
Cocktail of Disparate Technically Specialized Applications.....II-13
Biochips: By-product of Multi-disciplinary Sciences.....II-13
Nanotechnology.....II-13
1$100
   BioMEMS.....II-141$100
   Microfluidics.....II-15
Micro Total Analysis System.....II-15
1$100
  3. Biochip And Microarray Construction .....II-167 $500  
   Chip Architecture.....II-16
Essence of a Biochip.....II-16
Concept of a Microarray.....II-16
Microarray Modules.....II-16
1$100
   High Degree of Automation Spurs Biochips Use.....II-17
Microfabrication Technology in Biochips made from Polymer and Plastics.....II-17
Micro-optics in Biochips.....II-17
1$100
   Liquid Handling Through Micro-Dispensers.....II-18
Capillary Electrophoresis and Electrochemical Detectors.....II-18
Other Technologies.....II-18
Management of Bio-information.....II-18
Scanning.....II-18
1$100
   Microarray Database Management.....II-19
Classification of DNA Chips.....II-19
General Description of Spotted cDNA Microarrays.....II-19
Spotted DNA Arrays.....II-19
Spotted cDNA Versus Spotted Oligonucleotide Arrays.....II-19
1$100
   Limitations of Conventional cDNA Microarrays.....II-20
Protein Biochips.....II-20
1$100
   General Applications of Protein Biochips.....II-21
Challenges in the Design of a Protein Biochip.....II-21
Limitations of Protein Chip Technology.....II-21
1$100
   Advances by Companies.....II-22
Concluding Remarks for Protein Biochips.....II-22
1$100
  4. Applications of Biochips .....II-233 $300  
   Biochip Uses.....II-231$100
   Biochips and Pharmaceutical Investigation.....II-24
Biochips and Medical Diagnostics.....II-24
1$100
   Advantages of Biosensor Chip Technology.....II-25
Biochips and Forensics.....II-25
Biochips and Transplantation Screening.....II-25
Biochips and Identity Testing.....II-25
Biochips and Water and Environmental Testing.....II-25
Food Industry.....II-25
1$100
  5. Trends .....II-265 $500  
   Industry Characteristics.....II-26
New Products and Players to Drive Market.....II-26
Key Forces Boosting the Industry.....II-26
Industry Structure.....II-26
1$100
   Industry Challenges.....II-27
Price Dearness Pauses Biochips Growth.....II-27
Current Approaches to Biochips.....II-27
1$100
   The Business of Biochips.....II-28
Technological Trends.....II-28
Sensitivity.....II-28
1$100
   Microfabrication.....II-29
Density.....II-29
Integrated Chips.....II-29
Patent Trends.....II-29
1$100
   Patent Applications.....II-30
Table 1: Biochips Patent Applications (2003)-Percentage Breakdown by Geographic Region for US, China, Japan, Germany, South Korea, UK and Others (includes corresponding Graph/Chart).....II-30
1$300
  6. Next Generation Technology .....II-311 $100  
   Microfluidics Using CD-ROM Technology.....II-31
1$100
  7. Product Innovations and Developments .....II-3216 $1000  
   Affymetrix Introduces Complete Cytogenetic Solution.....II-32
Agilent Unveils 244K CGH Micro-Array.....II-32
Randox Unveils World’s First Protein Biochip.....II-32
Randox Introduces Thyroid Array Biochip.....II-32
1$100
   Sigma Launches ChIP Kit.....II-33
Randox Develops Biochip for Synthetic Steroids.....II-33
US and Czech Scientists to Develop Biochips for Detecting Cancer .....II-33
1$100
   febit Introduces New Geniom Biochip .....II-34
Agilent Introduces Additions to the HPLC-Chip Line for Proteomics.....II-34
1$100
   Progenika Develops BLOODchip.....II-35
Roche Introduces Gene Expression Services and Arrays.....II-35
Stratos Biosystems Develops New EC-Affinity Biochips.....II-35
1$100
   Affymetrix Unveils Affymetrix GeneChip Command Console Software .....II-36
Affymetrix Introduces GeneChip Mouse and Rat Gene 1.0 ST Arrays.....II-36
Affymetrix Unveils Genome-Wide Human SNP Array 6.0 .....II-36
1$100
   Caliper Life Sciences Launches High Throughput RNA Assay.....II-37
Applied Biosystems Unveils DNA Tools.....II-37
febit Launches Geniom RT Analyzer .....II-37
1$100
   Austrian Research Center Develops New Biochip Surface .....II-38
Researchers Develop Biochips to Eliminate Animal Testing.....II-38
Progenika Biopharma Launches IBD DNA .....II-38
1$100
   Bioident Develops New Lab-on-a-Chip Nanotiter Plate Prototype.....II-39
Ilochip and University of Denmark Develop a Biochip for Faster Bird Flu Detection
  .....II-39
CombiMatrix Develops a Biochip for Leukemia Analysis.....II-39
Affymetrix Launches New Tiling Arrays for Mapping Whole-Genome Transcript .....II-39
1$100
   Roche Plans to Launch AmpliChip in Japan.....II-40
Caliper Life Sciences Unveils Desktop Profiler.....II-40
Massachusetts Institute of Technology Develops Portable Lab on a Chip.....II-40
Optical Device to Develop Lab-on-a-Chip .....II-40
1$100
   Agilent Launches Five New HPLC Chips .....II-41
Protagen AG Launches New Protein Biochips.....II-41
Fluidigm Releases the 8.96 TOPAZ Screening Chip.....II-41
Affymetrix Releases Chip-on-Chip Array.....II-41
DNA Chip Research Launches High Sensitivity DNA Chip.....II-41
DNA Chip Research and HitachiSoft Unveils AceGene.....II-41
Affymetrix Introduces GeneChip® Human Exon Array.....II-41
1$100
   Affymetrix Announces Launch of GeneChip(R) Array Station.....II-42
Affymetrix Unveils GeneChip® Human Mapping 500K Arra Set.....II-42
Affymetrix Introduces GeneChip-Compatible™ Application Program.....II-42
Affymetrix Launches GeneChip(R) Scanner .....II-42
1$100
   Hitachi Develops RFID Sensor Chip for DNA Analysis.....II-43
Canon Develops DNA Chip on Inkjet Printer Technology.....II-43
Biacore Introduces Array-Based Protein Interaction Analysis Systems .....II-43
Caliper Launches Protein Express Assay for Electrophoresis System .....II-43
Affymetrix Rolls Out GeneChip(R) Globin-Reduction Kits and Protocol .....II-43
1$100
   Biacore Introduces Next Generation System for Protein Interaction Analysis (Sweden)
  .....II-44
Affymetrix and Invitrogen Launch Reagents for GeneChip Expression Array Platform
  .....II-44
Amersham Biosciences Extends CodeLink Range .....II-44
Ciphergen Showcases ProteinChip System- Series 4000.....II-44
1$100
   Affymetrix Rolls Out Plasmodium/Anopheles Genome GeneChip(R) Array .....II-45
SIRS-Lab Showcases Lab-Arraytor(R).....II-45
Affymetrix Unveils GeneChip(R) Array for Malaria Study .....II-45
Caliper Extends Portfolio of LabChip Microfluidic Systems .....II-45
Affymetrix Launches World’s First Diagnostic Microarray System (Europe) .....II-45
1$100
   Ushio’s biochip Machine for BioMEM and MicroTAS (Japan) .....II-46
Invitrogen Unveils Yeast ProtoArray .....II-46
Randox Showcases biochip Technology for Clinical Diagnostics (UK).....II-46
Zyomyx Introduces Murine Cytokine Biochip (US).....II-46
1$100
   Invitrogen Launches ProtoArray Human Protein Microarray.....II-47
Affymetrix Launches Plasmodium Genome GeneChip(R) .....II-47
1$100
  8. Recent Industry Activity .....II-4824 $1400  
   DNA Chip Acquires HuBit’s Gene Analysis Business.....II-48
Affymetrix Acquires USB .....II-48
Roche NimbleGen Forms Alliance with BioDiscovery to Provide CGH Solutions.....II-48
Illumina Announces Partnership with Genpathway for ChIP Sequencing Services.....II-48
1$100
   Jiangsu and IMDi Diagnosis to Establish Joint Venture .....II-49
Plexera Biosciences Enters into an Option Deal with Auguron .....II-49
1$100
   Affymetrix and Avesthagen Enter into an Agreement.....II-50
Roche NimbleGen and Affymetrix Announce Expansion of License Agreement.....II-50
Proteomika and Auguron Biosciences Ink Option Agreement.....II-50
1$100
   Gentel Biosciences and Eppendorf Enter into Global License Agreement .....II-51
GATC Biotech Establishes New Subsidiary.....II-51
1$100
   Procognia Spins off Sense Proteomic .....II-52
Johns Hopkins University Purchases MassARRAY System .....II-52
Yale University Purchases MassARRAY System .....II-52
Korea’s NIH Extends KARE Project with Affymetrix Technology.....II-52
1$100
   febit Obtains US Patent for Hybselect, a Microfluidic Extraction Method .....II-53
Roche Takes Over NimbleGen.....II-53
1$100
   GenTel BioSciences Acquires Protein Chip Platform Assets of GSK.....II-54
Advanced Liquid Logic Acquires Nanolytics .....II-54
Applied Microarrays Acquires Select GE Healthcare’s Assets.....II-54
1$100
   Canon, Toshiba and Other Companies to Join Hands for Biochips .....II-55
BioChip Innovations Signs Research Collaboration Agreement with IME .....II-55
1$100
   Protagen Enters into a Partnership to Develop Antibodies .....II-56
Spanish Society of Rheumatology Enters into Collaboration with Progenika .....II-56
Affymetrix and Partners Healthcare Extend Collaboration.....II-56
1$100
   Agencourt, NuGEN and Affymetrix Clinical Services Collaborate .....II-57
Affymetrix Inks Licensing Agreement with Empire Genomics.....II-57
Caliper Enters into a Licensing Agreement with Monogram Biosciences .....II-57
1$100
   Affymetrix and IPSOGEN Sign Agreement.....II-58
bioMérieux and NuGEN Enter into Supply and Cross-License Agreement.....II-58
1$100
   VWR and CapitalBio Enter into a Distribution Agreement .....II-59
C3B Bags Contract from Department of Defense to Develop an Implantable
  Biochip.....II-59
UCL Subsidiary and Roche Diagnostics Ink Licensing Deal.....II-59
Affymetrix Establishes the European Cytogenetic Research Initiative.....II-59
1$100
   Fluidigm Establishes New Development Center.....II-60
Daiichi Pure Chemicals Applies for Approval to Market DNA Micro-array.....II-60
GE Healthcare Snaps Up Biacore.....II-60
1$100
   Bio-Rad Acquires Ciphergen’s Life Science Research Business.....II-61
Sysmex to Form Partnership with Affymetrix.....II-61
Daiichi, Toshiba Hokuto and Toshiba Join Hands .....II-61
Affymetrix Collaborates with Zhejiang California Nanosystem Institute .....II-61
1$100
   Merck Sharp & Dohme and Shanghai Biochip Enter into Co- operation Agreement.....II-62
Toshiba Signs Licensing Agreement with Antara BioSciences.....II-62
MUSC Signs LOI with Lumera.....II-62
AVIVA Inks Agreement with Japan’s Cosmo Bio.....II-62
1$100
   Lumera Signs Collaborative Agreement with Harvard Medical School.....II-63
Whatman Receives CE Mark for CombiChip.....II-63
1$100
   IDIBAPS Led Project Receives Approval from European Union.....II-64
Toray to Establish DNA Chip Business .....II-64
Protagen Forays into the US Market.....II-64
Biacore Expands Operations into Chinese Market.....II-64
Nisshinbo to Replace Glass with Resin in DNA Production.....II-64
1$100
   OCIMUM Acquires a Division of MWG Biotech AG.....II-65
Biacore Acquires FLEXChip from HTS BioSystems .....II-65
Qiagen Acquires Assets of LumiCyte.....II-65
BD Sells Clontech.....II-65
Affymetrix Acquires ParAllele BioScience .....II-65
1$100
   Biacore Acquires FLEXChip System from HTS BioSystems .....II-66
Caliper Signs Purchase Agreement with Amphora .....II-66
Bio-Rad Inks Agreement with Caliper.....II-66
Toray Enters Joint Research Agreement with DNA Chip Research.....II-66
Ciphergen and Quest Diagnostics Partner for Proteomic Diagnostic Tests.....II-66
1$100
   Affymetrix and bioMerieux Extend Agreement .....II-67
bioMérieux Extend Collaboration Agreement with ExonHit Therapeutics.....II-67
Agilent Technologies Licenses Caliper's LabChip(R) Technology .....II-67
1$100
   Caliper and Predicant Biosciences Forge Licensing Agreement .....II-68
IntegraGen Signs Agreement with La Ligue Nationale Contre le Cancer.....II-68
GSK Selects Affymetrix GeneChip® 500K Array for Whole- Genome Association
  Studies.....II-68
Affymetrix Supplies GeneChip Technology to Veridex .....II-68
GE Acquires Amersham PLC.....II-68
1$100
   ViroLogic Merges with Aclara Biosciences.....II-69
Invitrogen Accredits Protein Chip Intellectual Property From Zyomyx.....II-69
Toshiba Collaborates with Osaka University.....II-69
Siemens, Infineon and Dr. Hintsche Plan Extended Alliance on Biochip Technology
  .....II-69
1$100
   Intel Eyes Biochips .....II-70
APAF and LumiCyte Join Hands in Proteomic Discovery .....II-70
Affymetrix and Caliper Life Sciences Join Forces for Target Preparation.....II-70
Affymetrix and TGen Collaborate to Offer Genotyping Services.....II-70
1$100
   Affymetrix Licenses GeneChip Technology to Veridex .....II-71
Affymetrix Grants Access to Aventis for GeneChip(R) Platform .....II-71
GeneChip Technology to Aid Neurological Disease Detection .....II-71
Affymetrix, ParAllele and Cambridge University Join Hands For Extensive
  Genotyping.....II-71
1$100
  9. Focus on Select Global Players .....II-723 $300  
   Affymetrix (US).....II-72
Applied Biosystems Group (US).....II-72
Biomerieux (France).....II-72
1$100
   Bio-Rad Laboratories, Inc. (US).....II-73
Caliper Technologies Corp (US).....II-73
Cepheid Inc. (US).....II-73
1$100
   GE Healthcare Ltd (UK).....II-74
Takara Bio, Inc. (Japan).....II-74
Zyomyx (US).....II-74
1$100
  10. Global Market Perspective.....II-75   
   Table 2: World Recent Past, Current & Future Analysis for Biochips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-751$300
   Table 3: World Long-term Projections for Biochips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-761$300
   Table 4: World 10-Year Perspective for Biochips by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-771$300
   Table 5: World Recent Past, Current & Future Analysis for DNA Chips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-781$300
   Table 6: World Long-term Projections for DNA Chips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-791$300
   Table 7: World 10-Year Perspective for DNA Chips by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-801$300
   Table 8: World Recent Past, Current & Future Analysis for Protein Chips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-811$300
   Table 9: World Long-term Projections for Protein Chips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-821$300
   Table 10: World 10-Year Perspective for Protein Chips by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-831$300
   Table 11: World Recent Past, Current & Future Analysis for Lab Chips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-841$300
   Table 12: World Long-term Projections for Lab Chips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-851$300
   Table 13: World 10-Year Perspective for Lab Chips by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-861$300
III. MARKET71$1950
  1. The United States.....III-125 $1075  
   A. Market Analysis.....III-1
Outlook.....III-1
Biochips Market Overview.....III-1
Time Saving Biochips - All Set to Grow.....III-1
Multiple Applications of Biochips Drive Sales.....III-1
1$75
   Biochip Market Faces Challenges.....III-2
Product Developments/Launches.....III-2
8$450
   Strategic Corporate Developments.....III-1012$650
   Key Player Review.....III-22
Affymetrix.....III-22
Applied Biosystems Group.....III-22
Bio-Rad Laboratories, Inc......III-22
1$75
   Clontech Laboratories, Inc......III-23
Caliper Life Sciences, Inc......III-23
Cepheid.....III-23
1$75
   Zyomyx.....III-24
B. Market Analytics .....III-24
Table 14: US Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-24
1$150
   Table 15: US Long-Term Projections for Biochips by Product Segment - DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-25

Table 16: US 10-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) .....III-25
1$150
  2. Canada .....III-262 $200  
   Market Analysis .....III-26
Table 17: Canadian Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-26
1$150
   Table 18: Canadian Long-Term Projections for Biochips by Product Segment - DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-27

Table 19: Canadian 10-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) .....III-27
1$150
  3. Japan .....III-288 $550  
   A. Market Analysis .....III-28
DNA Chip Based on Printing Technology.....III-28
DNA Chips to Reveal Links Among Genes.....III-28
1$75
   A leading Japanese Biochip Player - Takara Shuzo.....III-29
ICAN ™ Technology for Large-Scale Production of DNA Fragments.....III-29
1$75
   Product Launches.....III-30
Strategic Corporate Developments.....III-30
3$225
   Takara Bio Inc – A Key Player.....III-331$75
   B. Market Analytics .....III-34
Table 20: Japanese Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-34
1$150
   Table 21: Japanese Long-Term Projections for Biochips by Product Segment - DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-35

Table 22: Japanese 10-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) .....III-35
1$150
  4. Europe .....III-367 $625  
   A. Market Analysis .....III-36
Biochips Outlook in Europe.....III-36
European Advancements Shape Diagnostic Procedures.....III-36
1$75
   Product Launches.....III-37
Strategic Corporate Developments.....III-37
1$75
   B. Market Analytics .....III-38
Table 23: European Recent Past, Current & Future Analysis for Biochips by Geographic Region – France, Germany, UK, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-38
1$150
   Table 24: European Long-Term Projections for Biochips by Geographic Region – France, Germany, UK, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-391$150
   Table 25: European 10-Year Perspective for Biochips by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, UK, and Rest of Europe Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-401$150
   Table 26: European Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-41

Table 27: European Long-Term Projections for Biochips by Product Segment - DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-41
1$150
   Table 28: European 10-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-42
1$150
  4a. France .....III-434 $300  
   A. Market Analysis .....III-43
Strategic Corporate Developments.....III-43
1$75
   Biomerieux – A Major Player.....III-441$75
   B. Market Analytics .....III-45
Table 29: French Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-45

Table 30: French Long-Term Projections for Biochips by Product Segment - DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-45
1$150
   Table 31: French 10-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-46
1$150
  4b. Germany .....III-474 $300  
   A. Market Analysis .....III-47
Berlin, Brandenburg and Biochips.....III-47
Product Launch.....III-47
1$75
   Strategic Corporate Developments.....III-481$75
   B. Market Analytics .....III-49
Table 32: German Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-49

Table 33: German Long-Term Projections for Biochips by Product Segment - DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-49
1$150
   Table 34: German 10-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-50
1$150
  4c. The United Kingdom .....III-514 $300  
   A. Market Analysis .....III-51
Product Launches.....III-51
1$75
   Strategic Corporate Developments.....III-521$75
   GE Healthcare Ltd – A Key Player.....III-53
B. Market Analytics .....III-53
Table 35: UK Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-53
1$150
   Table 36: UK Long-Term Projections for Biochips by Product Segment - DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-54

Table 37: UK 10-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) .....III-54
1$150
  4d. Rest of Europe .....III-557 $525  
   A. Market Analysis .....III-55
Status of Proteomics in Finland.....III-55
Product Developments/Launches.....III-55
2$150
   Strategic Corporate Developments.....III-572$150
   B. Market Analytics .....III-59
Table 38: Rest of Europe Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-59
1$150
   Table 39: Rest of Europe Long-Term Projections for Biochips by Product Segment - DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-601$150
   Table 40: Rest of Europe10-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) .....III-61
1$150
  5. Rest of World .....III-6210 $675  
   A. Market Analysis .....III-62
China.....III-62
Basic Environment and Commercial Development.....III-62
Biochip Research.....III-62
1$75
   Status of Biochip Industry in China.....III-63
Historic Review - Chinese Government Chips in.....III-63
1$75
   Novel Technologies - Top on China’s Agenda.....III-64
Taiwan.....III-64
Taiwan Pursues Promise of Biochip Sector.....III-64
International Advantage Sought.....III-64
1$75
   Strategic Corporate Developments .....III-654$300
   B. Market Analytics .....III-69
Table 41: Rest of World Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-69
1$150
   Table 42: Rest of World Long-Term Projections for Biochips by Product Segment - DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-701$150
   Table 43: Rest of World 10-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) .....III-711$150
IV. COMPETITIVE LANDSCAPE 166$995
  
Total Companies Profiled: 89 (including Divisions/Subsidiaries - 100)

Region/Country                 Players


The United States                 53   
Japan                             12
Europe                            28
     France                        6
     Germany                       8
     The United Kingdom            5
     Spain                         1
     Rest of Europe                8
Asia-Pacific (Excluding Japan)     7
Click here to request a full table of contents and more details on this project.		  
 
 
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

© Copyrights 2009, Global Industry Analysts, Inc., USA.